“These reforms mark a pivotal moment for UK clinical research. Speed and agility matter, but trust, ethics and patient centricity matter just as much. What is encouraging is that the MHRA is actively balancing innovation with safety, while promoting earlier and more meaningful engagement with sponsors.” Lisa J Talbot, CEO of Absolutely Health